Brought to you by 
Foundation Medicine gets $7mm in Series A round; adds on later
06 Dec 2011
Executive Summary
Cancer-focused diagnostics start-up Foundation Medicine Inc. (personalized medicine using genome analysis) has brought in $7mm of a potential $25 million Series A financing round led by Third Rock Ventures.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Foundation Medicine gets $7mm in Series A round; adds on later
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice